Phospho-p38 MAPK (Thr180) Recombinant Rabbit mAb (S-1553-9)
Mitogen-activated protein kinase 14,MAP kinase 14,MAPK 14,Cytokine suppressive anti-inflammatory drug-binding protein (CSAID-binding protein,CSBP),MAP kinase MXI2,MAX-interacting protein 2,Mitogen-activated protein kinase p38 alpha (MAP kinase p38 alpha),Stress-activated protein kinase 2a (SAPK2a),CSBP,CSBP1,CSBP2,CSPB1,MXI2,SAPK2A,MAPK14
产品介绍 FAQs 评论(0)
宿主来源
Rabbit抗原名称
Phospho-p38 MAPK (Thr180)分子别名
Mitogen-activated protein kinase 14; MAP kinase 14; MAPK 14; Cytokine suppressive anti-inflammatory drug-binding protein (CSAID-binding protein; CSBP); MAP kinase MXI2; MAX-interacting protein 2; Mitogen-activated protein kinase p38 alpha (MAP kinase p38 alpha); Stress-activated protein kinase 2a (SAPK2a); CSBP; CSBP1; CSBP2; CSPB1; MXI2; SAPK2A; MAPK14免疫原
Synthetic Peptide细胞定位
Cytoplasm, NucleusAccession
Q16539克隆号
S-1553-9抗体类型
Recombinant mAb抗体同种型
IgG翻译后修饰类型
磷酸化反应种属 ?
Hu, Ms, Rt预测反应种属
(反应种属缩写表)Dg, Cp, Cz, Zf纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
WB
稀释度
应用 稀释度 推荐种属 Dot Blot 1:1000 WB 1:1000 Hu, Ms, Rt
Phospho-p38 MAPK (Thr180) is the dual-phosphorylated, enzymatically active form of the p38 mitogen-activated protein kinase in which the conserved threonine residue at position 180 (within the canonical Thr-X-Tyr activation motif, TGY in human p38α) is phosphorylated, together with Tyr182, by upstream MAP kinase kinases (MKK3/6 or MKK4), resulting in a conformational switch that opens the ATP- and substrate-binding sites, thereby enabling the kinase to transduce stress, inflammatory, and cytokine signals to downstream transcription factors (e.g., ATF-2, CHOP, MEF2C) and other effectors, ultimately governing cellular responses such as apoptosis, differentiation, and cytokine production.
免疫印迹
WB result of Phospho-p38 MAPK (Thr180) Recombinant Rabbit mAb
Primary antibody: Phospho-p38 MAPK (Thr180) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated HeLa whole cell lysate 20 µg
Lane 2: HeLa treated with 25 μM Anisomycin for 30 minutes whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 41 kDa
Observed MW: 38 kDaWB result of Phospho-p38 MAPK (Thr180) Recombinant Rabbit mAb
Primary antibody: Phospho-p38 MAPK (Thr180) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated C6 whole cell lysate 20 µg
Lane 2: C6 treated with 25 μg/ml Anisomycin for 30 minutes whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 41 kDa
Observed MW: 38 kDa
斑点杂交
Dot blot result of Phospho-p38 MAPK (Thr180) Recombinant Rabbit mAb
Lane 1: p38 MAPK (Thr180) phospho peptide 1
Lane 2: p38 MAPK (Thr180) phospho peptide 2
Lane 3: p38 MAPK (Thr182) phospho peptide
Lane 4: p38 MAPK unmodified peptide
Primary antibody: Phospho-p38 MAPK (Thr180) Recombinant Rabbit mAb at 1/1000 dilution
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
FAQs
我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定
我们推荐客户使用TPST+5%脱脂奶粉来稀释一抗,进行封闭。 虽然BSA被推荐为WB检测磷酸化蛋白的常用封闭剂,但是脱脂奶粉获取更加方便,覆盖更广泛的非特异性结合位点,在一抗性能优越的前提下,使用脱脂奶粉封闭性价比更高







评论(0)